Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Analytical Chemistry

Mapping Out Lipids

Mass spectrometry imaging provides a means for monitoring the distributions of lipids in tissue from diseased liver biopsies

by Celia Henry Arnaud
April 6, 2009 | A version of this story appeared in Volume 87, Issue 14

[+]Enlarge
Credit: Anal. Chem.
TOF-SIMS image of liver tissue reveals distribution of a C34 diacylglycerol, with yellow marking the highest intensity.
Credit: Anal. Chem.
TOF-SIMS image of liver tissue reveals distribution of a C34 diacylglycerol, with yellow marking the highest intensity.

French researchers have used mass spectrometry imaging to map the distributions of lipids in biopsies of patients with nonalcoholic fatty liver disease (Anal. Chem., DOI: 10.1021/ac900045m). In this disease, triacylglycerols (TAGs) and diacylglycerols (DAGs) accumulate in the liver. Alain Brunelle of the Institute of Natural Substances Chemistry, in Gif-sur-Yvette, and coworkers used time-of-flight secondary-ion mass spectrometry (TOF-SIMS) to map the lipids in liver tissue samples at the micrometer scale. One hallmark of nonalcoholic fatty liver disease is a condition known as steatosis, which is characterized by the formation of vesicles enriched in lipids, especially TAGs and DAGs. In steatotic regions of the liver samples, the researchers observed the accumulation of TAGs, DAGs, monoacylglycerols, and fatty acids. They detected more DAGs than TAGs, even though TAGs are usually a major component of steatotic vesicles. Some of the observed DAGs could be the result of TAG fragmentation in the mass spectrometer source, the researchers note. They also compared the lipid profiles of nonsteatotic regions of fatty liver with those of normal liver and found significant differences in lipid composition. Such measurements could help understand the earliest stages of nonalcoholic fatty liver disease.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.